Allianz’s Zimmer Biomet ZBH Stock Holding History

Allianz’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.74M	Hold	43,500	–	–	0.04%	218
2026 Q1	$3.93M	Hold	43,500	–	–	0.04%	205
2025 Q4	$3.91M	Buy	43,500 +14,500	+50%	+$1.37M	0.05%	171
2025 Q3	$2.86M	Hold	29,000	–	–	0.06%	166
2025 Q2	$2.65M	Hold	29,000	–	–	0.06%	166
2025 Q1	$3.28M	Sell	29,000 -404	-1%	-$43.2K	0.09%	147
2024 Q4	$3.1M	Buy	29,404 +404	+1%	+$43.3K	0.08%	143
2024 Q3	$3.13M	Buy	29,000 +25,966	+856%	+$2.83M	0.08%	142
2024 Q2	$329K	Sell	3,034 -4,390	-59%	-$518K	0.01%	298
2024 Q1	$980K	Buy	+7,424	New	+$927K	0.03%	222

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Allianz's ZBH Position: Q2 2026 in Review

Allianz held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 43,500 shares worth $3.74M. The position accounts for 0.04% of the portfolio, ranked #218.

Allianz first reported a position in ZBH in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.93M in Q1 2026. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Allianz held 43,500 shares of Zimmer Biomet worth $3.74M as of Q2 2026.
Allianz left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up 0.04% of Allianz's portfolio in Q2 2026, its #218 holding.
Allianz first reported a position in Zimmer Biomet in Q1 2024 and has held it in 10 quarters since.
Allianz's Zimmer Biomet position peaked at $3.93M in Q1 2026.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.